PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
70.23
ESG score 1.1-1.2x Healthcare median of 59.62. Philip Fisher would examine if superior ESG practices support long-term growth and stakeholder loyalty.
70.45
Environmental score exceeding 1.2x Healthcare median of 57.54. Joel Greenblatt would verify if this climate leadership creates pricing power and regulatory advantages.
73.58
Social score exceeding 1.2x Healthcare median of 60.17. Joel Greenblatt would verify if this social leadership translates to employee productivity and customer loyalty advantages.
66.65
Governance score 1.1-1.2x Healthcare median of 61.10. Philip Fisher would examine if superior governance practices support long-term value creation.